Portfolio 2010

Company: DCPrime B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2010
Status: Realized

DCPrime is a biotech company with a proprietary allogeneic dendritic cell line as a platform to derive and develop the next generation therapeutic dendritic cancer vaccines.